Combined Src and MEK inhibition decreases ovarian cancer (OVCA) cell growth, tumorigenicity and aldehyde dehydrogenase positive tumor-initiating-cells Conference

Simpkins, F, Hew, K, Azzam, D et al. (2015). Combined Src and MEK inhibition decreases ovarian cancer (OVCA) cell growth, tumorigenicity and aldehyde dehydrogenase positive tumor-initiating-cells . CLINICAL CANCER RESEARCH, 21 10.1158/1557-3265.OVCASYMP14-POSTER-THER-1431

cited authors

  • Simpkins, F; Hew, K; Azzam, D; Wei, Z; Zhang, G; Sun, J; Zhang, D; Jang, K; Liu, W; Lu, Y; Mills, G; Tan, I; Slingerland, J

authors

date/time interval

  • September 8, 2014 -

publication date

  • August 15, 2015

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Seattle, WA

Conference

  • 10th Biennial Ovarian Cancer Research Symposium

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 21